CCMW
ENZ

Cypress Capital Management (Wyoming)’s Enzo Biochem, Inc. ENZ Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-275
Closed -$3K – 336
2017
Q3 		$3K Hold
275
– – ﹤0.01% 256
2017
Q2 		$3.04K Hold
275
– – ﹤0.01% 243
2017
Q1 		$2.3K Buy
+275
New +$1.94K ﹤0.01% 254

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s ENZ Position: Q4 2017 in Review

Cypress Capital Management (Wyoming) sold out of Enzo Biochem, Inc. (ENZ) in Q4 2017, closing a stake of 275 shares — an estimated $3K sold.

Cypress Capital Management (Wyoming) first reported a position in ENZ in Q1 2017 and held it in 3 quarters. The position peaked at $3.04K in Q2 2017. 115 funds tracked by Wall St. Rank hold ENZ as of Q4 2017.

  • Cypress Capital Management (Wyoming) reported no remaining Enzo Biochem, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 275 Enzo Biochem, Inc. shares in Q4 2017, an estimated $3K.
  • Cypress Capital Management (Wyoming) first reported a position in Enzo Biochem, Inc. in Q1 2017 and held it in 3 quarters.
  • Cypress Capital Management (Wyoming)'s Enzo Biochem, Inc. position peaked at $3.04K in Q2 2017.
  • 115 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2017.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q4 2017, filed 31 Jan 2018.